-
The Institute for Clinical and Economic Review’s Incorrect Use of Incremental Cost-Effectiveness Ratios
Mar 10, 2025, 14:00 PM -
Colorectal Cancer Screening Initiation Among Newly Age-Eligible Medicaid-Insured Individuals in Texas
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
Incorporating Caregiver Burden in Japans Cost-Effectiveness Evaluation: A Case Study of Teduglutide for Pediatric Short Bowel Syndrome
Mar 10, 2025, 14:00 PM -
State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials
Mar 10, 2025, 14:00 PM -
A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians
Mar 10, 2025, 14:00 PM -
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 60 Years with Cardiopulmonary Disease
Mar 10, 2025, 14:00 PM -
Colorectal Cancer Screening Initiation Modalities Among Newly Age-Eligible Medicaid-Insured Individuals in Texas
Mar 10, 2025, 14:00 PM -
Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer
Mar 10, 2025, 14:00 PM -
Costs of Initiated Potentially Inappropriate Medication in 2021-2022 in Quebec, Canada
Mar 10, 2025, 14:00 PM -
National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States
Mar 10, 2025, 14:00 PM -
Trends and Disparities in Weight Loss Activities Among Adults With Prediabetes and Obesity in the United States: 2009-2020
Mar 10, 2025, 14:00 PM -
Relationship between Genetic Polymorphisms and Clinical Parameters in Mexican Postmenopausal Women: A Study on Cardiovascular Health
Mar 10, 2025, 14:00 PM -
A Review of Guidelines and Checklists for the Use of Artificial Intelligence/Machine Learning (AI/ML) in Evidence Generation: Current Landscape and Recommendations
Mar 10, 2025, 14:00 PM -
Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study
Mar 10, 2025, 14:00 PM -
Is the Biologics Price Competition and Innovation Act Working as Intended?
Mar 10, 2025, 14:00 PM -
Gender Differences in Use of Cerebrospinal Fluid Biomarker Test and Positron Emission Tomography for Diagnosing Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Real World Setting
Mar 10, 2025, 14:00 PM -
Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Real-World Patient Persistence and Adherence: A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population
Mar 10, 2025, 14:00 PM